Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer

NCT03487939 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms
Drug Therapy

Interventions

DRUG: FOLFOXIRI

Sponsor

China Medical University, China